BIAL - Portela

Privately-held (family-owned) pharmaceutical company

Privately held: no public share price · Portugal

Assets

(3 total)
3Total Assets
2Approved
0Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
Showing 3 of 3 assets
Target & Modality
Approved
Voltage-gated sodium channelSmall molecule
Epilepsy
Focal Onset Seizures
Opicapone(Ongentys)
Approved
COMTSmall molecule
Parkinson's Disease
ZamicastatNo recent activity
Phase 2
DBHSmall molecule
Pulmonary Arterial Hypertension

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.